OSCR:NYE-Oscar Health Inc (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 20.96

Change

-1.26 (-5.67)%

Market Cap

USD 5.13B

Volume

3.82M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 455.93B
ELV Elevance Health Inc

N/A

USD 125.26B
CI Cigna Corp

N/A

USD 95.46B
CVS CVS Health Corp

N/A

USD 76.20B
HUM Humana Inc

N/A

USD 42.39B
CNC Centene Corp

N/A

USD 37.96B
MOH Molina Healthcare Inc

N/A

USD 18.18B
NEUE NeueHealth Inc

N/A

USD 0.05B

ETFs Containing OSCR

DDOC:XETRA Global X Telemedicine & D.. 4.48 % 0.00 %

N/A

USD 5.39M
DDOC:F Global X Telemedicine & D.. 4.48 % 0.00 %

N/A

USD 4.76M
EDOC:SW Global X Telemedicine & D.. 4.48 % 0.00 %

N/A

USD 4.69M
EDOC:LSE Global X Telemedicine & D.. 4.17 % 0.00 %

N/A

USD 4.72M
EDOG:LSE Global X Telemedicine & D.. 4.16 % 0.00 %

N/A

USD 0.15M
FFTY Innovator IBD® 50 ETF 0.00 % 0.80 %

N/A

USD 0.09B
FYC First Trust Small Cap Gro.. 0.00 % 0.70 %

N/A

USD 0.27B
FYX First Trust Small Cap Cor.. 0.00 % 0.63 %

N/A

USD 0.85B
EDOC Global X Telemedicine & D.. 0.00 % 0.00 %

N/A

USD 0.05B

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 129.07% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 129.07% 100% F 100% F
Trailing 12 Months  
Capital Gain 195.21% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 195.21% 100% F 99% N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 19.14% 88% B+ 83% B
Dividend Return 19.14% 75% C 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 98.98% 13% F 7% C-
Risk Adjusted Return 19.34% 25% F 41% F
Market Capitalization 5.13B 22% F 76% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector